Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2800 participants.
Also called NCT05476991
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 2,800 participants
- Registry
-
NCT05476991
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Recruiting
Technical summary
Registry record NCT05476991. Randomized; no masking; primary purpose treatment. Start 2023-05-17 (actual); primary completion 2027-09-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
- Acronym
- RIISC-THETIS
- Condition
- Stroke
- Condition
- Stroke, Ischemic
- Condition
- Atherosclerosis
- Condition
- Myocardial Infarction
- Condition
- Coronary Syndrome
- Condition
- TIA (transient ischemic attack)
- Condition
- Cardiac Disease
- Condition
- Cerebral Infarction
- Intervention (Drug)
- Colchicine 0.5 MG
- Intervention (Drug)
- Ticagrelor 90mg
- Intervention (Drug)
- Aspirin 75-300mg
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
Record details
- Record id
cardio:ct-nct05476991- Content hash
9877b2a6ed2209e20dfc3a3c9721f1e09ffab035562d441bbb5d243d634ab5c0